We have evaluated the expression of growth factor receptors (GFRs) on early hematopoietic progenitor cells IHPCS) purified from human adult peripheral blood and induced in liquid suspension culture to unilineage differentiationlmaturation through the erythroid (E), granulocytic (GI, megakaryocytic (Mk), or monocytic (Mol lineage. The receptors for basic fibroblast GF (bFGF 1, erythropoietin (Epo), thrombopoietin (Tpo), and macrophage colony-stimulating factor (M-CSF) have been only assayed at mRNA level; the majority of GFRs have been evaluated by both mRNA and protein analyses: the expression patterns were consistent at both levels. In quiescent HPCs the receptors for early-acting [fk3 ligand (FL), c-kit ligand (KL), bFGF, interleukin-6 (IL-611 and multilineage [IL-3, granulocyte-macrophage CSF (GM-CSFII HGFs are expressed at significant levels but with different patterns, eg, kit and ftf3 are detected on a majority and minority of HPCs, respectively, whereas IL-3Rs and GMCSFRs are present on almost all HPCs. In the four dfferentiation pathways, expression of early-acting receptors shows a progressive decrease, more rapidly for bFGFR-1 and fct3 than for c-kit; furthermore, c-kit is more slowly downmodulated in the E and Mk than the G and Mo lineages. As a partial exception, IL-6Rs are still detected through the early or late stages of maturation in the Mk and M o lineages, respectively. IL-3R expression is progressively and rapidly downmodulated in both E and Mk pathways, whereas it EMATOPOIESIS IS sustained by a pool of hematopoi-
MK, CFU-MK), the granulocyte-monocytic series (CFU-GM, CFU-G, CFU-M), as well as multipotent CFUs for all four lineages (CFU-GEMM). HPCs in turn differentiate into morphologically recognizable precursors that mature to terminal elements circulating in peripheral blood (PB).
The survival, growth, and differentiation of hematopoietic cells is at least in part regulated by a network of hematopoietic growth factors (HGFs) termed colony-stimulating factor (CSF) or interleukin (IL).' Erythropoietin (Epo), G-CSF, thrombopoietin (Tpo), and M-CSF essentially stimulate late unilineage HPCs (CFU-E, CFU-G, CFU-MK, and CFU-M, respectively) and the derived differentiated precursors. Multilineage HGFs, including IL-3 and GM-CSF, affect CFU-GEMM and early unilineage or bilineage HPCs (BFU-E, BFU-MK, and CFU-GM).' Other cytokines Vft3 and ckif ligands (FL, KL), basic fibroblast GF (bFGF), leukemia inhibitory factor (LIF), and IL-61 act on the primitive stages of hematop~iesis.~-~ The availability of recombinant HGFs favored analysis of their cell-surface receptors (Rs). HGFRs have been recently cloned and classified into three different categories: (1) Rs belonging to the Ig superfamily," eg, IL-1R and plateletmoderately decreases in the Mo lineage and is sustained in the G series. The expression of GM-CSFR is gradually downmodulated in all differentiation pathways, ie, the receptor density markedly decreases but late erythroblasts are still partially GM-CSFR' and terminal G, Mk and Mo cells are essentially GM-CSFR+. Expression of receptors for late-acting cytokines is lineage-specific. Thus, EpoR, G-CSFR. TpoR, and M-CSFR exhibit a gradual induction followed by a sustained expression in the E, G, MK, and M o lineages, respectively. In the other differentiation pathways the expression of these receptors is either absent or initially low and thereafter suppressed. These observations are compatible with the following multi-step model. derived growth factor receptor (PDGFR); (2) Rs belonging to the tyrosine kinase superfamily," namely the receptors for CSF-I (M-CSF) and steel factor, encoded by the c-fms and c-kit proto-oncogenes, respectively, and the $t3/FLK2 receptor; and (3) Rs belonging to the peculiar highly conserved ''cytokines receptor ~uperfamily"'~~'~ which includes IL-2RP chain, IL-4R, ILdR, IL-3Ra chain, GM-CSFRa chain, G-CSFR, and EpoR.
Elucidation of HGFR control mechanisms is obviously crucial to unveil the cellular and molecular basis of hematopoiesis, particularly at the level of HSCsMPCs. Our laboratory has shown that purified PB HPCs express high-affinity HGFRs, with prevalent IL-3R, a lower level of IL-6Rs and GM-CSFRs and barely detectable levels of EpoRs.14 Subse-
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TESTA ET AL quent studies by double labeling of total human'' or Rhesus monkey bone marrow (BM) ~e l l s '~~' ' with anti-CD34 and either anti-IL-3R or GM-CSFR monoclonal antibodies (MoAbs) confirmed that CD34+ cell subsets express IL-3Rs andor GM-CSFRs. Furthermore, studies on fractionated BM CD34' cells showed that small cells possess a higher IL-6R, IL-3R, and GM-CSFR density than large ones.'' These studies did not provide insight into the expression pattern of HGFRs during HPC differentiatiordmaturation along the diverse hematopoietic lineages. We have recently developed methodology that enables stringent purification and abundant recovery of PB HPCS~.'~-'' and their selective unilineage differentiation along the erythroid (E),19-24 granulocytic (G),23.24 megakaryocytic (Mk),*' or monocytic (Mo)~ lineage. The availability of these experimental tools allowed us to explore the expression of HGFRs at different stages of HPC differentiatiordmaturation restricted along the E, G, Mk, or Mo pathway.
MATERIALS AND METHODS

HGFs and Culture Medium
Recombinant human IL-3 (rhIL-3; 2 X IO6 Ulmg), rhGM-CSF, and rhIL-6 (2 X 10* Ulmg) were supplied by the Genetics Institute (Cambridge, MA); rhEpo (1.2 x lo5 U/mg) and bovine basic fibroblast GF (rbFGF; 2 x lo7 U/mg) by Amgen (Thousand Oaks, CA); and rhFL (1.9 X lo6 U/mg) and rhKL (1 X 1 O5 Ulmg) by Immunex (Seattle, WA). rhG-CSF (1 X 10' Ulmg) and rhM-CSF (6 x lo7 U/ mg) were purchased from R&D Systems (Minneapolis, MN), and rhTpo was generously provided by Genentech (San Francisco, CA). Iscove's modified Dulbecco's medium (IMDM; GIBCO, Grand Island, NY) was prepared weekly before each purification experiment.
Adult PB HPC Purc9cation
Adult PB was obtained from male donors after informed consent as described.' HPCs were purified as reported7.I9 and modified.*@" Briefly, (IA) PB samples were separated over a Ficoll-Hypaque density gradient (Pharmacia, Piscataway, NJ), and (IB) PB mononuclear cells (PBMCs) resuspended in IMDM containing 20% heat-inactivated fetal calf serum (FCS; GIBCO) for three cycles of plastic adherence. Thereafter, (11) cells were separated by centrifugation on a discontinuous Percoll gradient (Biochrom KG, Berlin, Germany). (111)
Step 111 purification was potentiated (Step IIIP) as
HPC Clonogenetic Assay
In FCS' cultures purified HPCs were seeded ( I X 10' cells/mL/ dish, two or three plates per point) and cultured in 0.9% methylcellulose, 40% FCS in IMDM supplemented with a-thioglycerol mol/L) (Sigma, St Louis, MO), ferric ammonium citrate (10 mg/ mL), pure human transferrin (0.7 mg/mL), and different HGFs as detailed below at 37°C in a 5% COz/5% OZ/90% NZ humidified atmosphere. In FCS-cultures,26 FCS was substituted by bovine serum albumin (BSA), pure human transferrin, human low-density lipoproteins, insulin, sodium pyruvate, L-glutamine (2 X lo-' mol/ L), rare inorganic elementsz7 supplemented with iron sulfate (4 X IO-* mom), and nucleosides. Both FCS+ and FCS-cultures were supplemented with FL (100 ng/mL), KL (100 ng), IL-3 (100 U), GM-CSF (10 ng), Epo (3 U), M-CSF (250 U), and G-CSF (500 U). CFU-GEMM, BFU-E, and CFU-GM colonies were scored on day 14-15 and 16-18 in FCS" and FCS-cultures, respectively.
Unilineage HPC Liquid Suspension Culture
Step IIIP HPCs were seeded ( 5 X IO4 cells/mL) and grown in liquid suspension culture supplemented with the following HGFs: (1) in FCS-erythropoietic culture, very low doses of 1L-3 (0.01 U/ mL) and GM-CSF (0.001 ng) and a saturating level of Epo ( 3 U)"'-''; (2) in FCS-granulopoietic culture, low amounts of IL-3 ( I U) and GM-CSF (0.1 ng) and saturating amounts of G-CSF (500 U)23,'4; (3) in FCS-megakaryocytopoietic culture, saturating doses of Tpo (100 ng)*'; and (4) in FCS+ monocytopoietic culture, saturating amounts of both FL (100 ng) and M-CSF (500 U).' Cells were periodically counted and analyzed for morphology, membrane phenotype, and HGFR expression at both mRNA and protein levels.
Unilineuge HPC Clonogenetic Culture
HPCs growing in unilineage liquid suspension cultures were assayed in unilineage clonogenetic cultures. These were performed by adding the HGF stimuli used for unilineage liquid suspension cultures (see above) in FCS-(erythropoietic, granulopoietic, megakaryocytopoietic cultures) or FCS' (monocytopoietic culture) medium (see above). Mk colonies were scored on day 10-I2 and other colonies on day 14-16, The scoring threshold was 100 cells/colony for erythroid, granulocytic, and monocytic clones and 3 celldcolony for megakaryocytic ones.
Control Cells
Normal human adult fibroblasts, PB granulocytes, and monocytes were obtained by standard procedures. Fetal liver erythroblasts were obtained as described." Human TF-1, K562, U937, KG I , HL-60, and HEL leukemic cell lines were grown under standard conditions.
Immunojluorescence HPC Analysis
Anti-CD34 (8G12 clone), -HLA-DR, -CD38, -CD61, -VLA-4, -CD3 I , -CD58, -CD44, -CD4 (Becton Dickinson, Mountain View, CA), +kit, -gp170 (Immunotech, Marseille, France), and -Thy-I (PharMingen, San Diego, CA) MoAbs directly conjugated with fluorochrome [fluorescein isothiocyanate (FITC) or phycoerythrin (PE)] were used to characterize the membrane phenotype of step IIIP HPC.
Cells were washed twice in phosphate-buffered saline (PBS) and then incubated for 60 minutes at 4°C in the presence of an appropriate amount of MoAb. After three washes with cold PBS, cells were resuspended in PBS containing 2.5% formaldehyde and then analyzed by FACS (FACScan; Becton Dickinson) for fluorescence intensity with a program suitable for doubleimmunofluorescence analysis. At least 4,000 cells were analyzed for each determination. The gating for analysis of the living cell population was determined by propidium iodide staining.*x
MoAbs.
Labeling procedure.
Fluorescence Analysis of HGFR Expression
Two types of reagents were used: ( I ) anti-HGFR MoAbs either simply purified or fluorochrome-conjugated; and (2) recombinant HGFs either biotin or fluorochrome conjugated. All reagents are listed in Table 1 .
PE-labeled anti IL-3R a-chain MoAb, clone 9G5"' was purchased from PharMingen; PE-labeled anti-c-kit was obtained from Immunotech: PE-labeled anti-jf3, clone SF1.3403" was kindly supplied by Dr 0. Rosnet (Marseille, France). These antibodies were incubated as indicated above for fluorochrome-conjugated antibodies.
Control experiments for exogenous ligand versus MoAb competition were performed by incubating the step IIIP cells with a fixed Anti-GM-CSFR MoAb. Purified unconjugated anti-GM-CSFR a-chain MoAb, clone 17-A3' was purchased from PharMingen. Cells were first incubated for 60 minutes at 4°C in the presence of 2.5 mg/mL of this antibody, washed with cold PBS, and then incubated for 30 minutes at 4°C with biotin-conjugated sheep anti-mouse IgGs (Cappel, West Chester, PA). After washing with cold PBS, cells were incubated with Quantum Red-labeled streptavidin (Sigma) and then analyzed by fluorescence-activated cell sorting (FACS).
Control experiments for exogenous ligand versus MoAb competition were performed by incubating the step IIIP cells in the presence of a fixed amount of anti-GM-CSFR MoAb combined or not with increasing concentrations of GM-CSF (0.001, 0.1, or 100 ng/mL). No competition was observed at the cytokine dosage supplemented in E and G cultures (data not shown).
Biotin-conjugated c-kit and IL-6 were obtained from R&D Systems. Cells were incubated for 60 minutes at 4°C with this reagent, incubated for an additional 30 minutes at 4°C with PElabeled streptavidin (R&D Systems), and then analyzed by FACS.
PE-labeled GM-CSF and G-CSF were obtained from R&D Systems. The cells were incubated for 60 minutes at 4°C with this reagent, washed, and then analyzed by FACS.
G-CSF was added at saturating level in G culture. To assay the binding of PE-labeled G-CSF in G culture, cells were first (1) washed twice in neutral PBS, treated with 1 mL of cold PBS (titrated to pH 3.0 with HCl) for 1 minute at 4°C to remove the large majority of surface-bound G-CSF, washed once with neutral PBS; and then (2) incubated with PE-labeled G-CSF this procedure allows removal of greater than 95% surface-bound G-CSF (see Results). As for GM-CSF, we previously showed that the GM-CSF concentrations used in E and G cultures cause less than 5% receptor o c c~p a n c y '~ (see also Results).
The specificity of biotinylated and PE-conjugated ligands (KL, IL-6, GM-CSF, G-CSF) was assessed by using TFI erythroleukemic Ligands.
cells incubated with ligand alone or combined with an appropriate amount of blocking antiligand MoAb: the difference in fluorescence intensity between these two conditions reflects the level of specific binding and the number of receptors (Fig 1) .
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) Analysis of HGFR mRNA
Total RNA, extracted by the guanidium isothiocyanate method3* in the presence of 12 mg of Escherichia coli rRNA as a carrier, was normalized by dot hybridization with a human rRNA probe." The normalized RNA was reverse transcribed according to the manufacturer's instructions (GIBCO-BRL, Gaithersburg, MD). The RT-PCR was normalized for P2-mi~roglobulin'~ (amplification within the linear range was achieved by 20 PCR cycles: denaturation at 95°C for 30 seconds, annealing at 54°C for 30 seconds, and extension at 72°C for 45 seconds). To evaluate the expression of HGFR genes, an aliquot of RT-RNA (corresponding to -2 ng RNA) was amplified within the linear range by 30 PCR cycles. Each sample was electrophoresed in 2% agarose, transferred to nylon membrane, and hybridized with a specific probe. Positive controls (detailed in Results) were normalized for P2-microglobulin and included in all PCR assays. For negative controls, an aliquot of RNA (-2 ng) from each sample was amplified to exclude the presence of contaminant DNA; a mock reaction was also included. PCR cycles: 95"C/30 seconds, 55"C/30 seconds, 72"C/45 seconds (except when otherwise indicated). 
Primers and Probes
RESULTS
HPC Purijication and Membrane Phenotype
Early HPCs were purified from PB by a methodology previously de~cribed'.'~ and recently The Step IIIP cells are intensively CD34' (Fig 3) over the negative background and 5% to 15% of these are positive for Thy-I and gp170 membrane antigens, which are expressed on putative HSCs and primitive HPCS.~'." The large majority of step IIIP HPCs are CD38' and HLA-DR', but 5% to 10% are CD34'/CD38'"" and CD34'kILA-DR""". Only a minority (5% to 10%) of CD34' step IIIP cells are positive for a few lineage-specific differentiation antigens, such as CD4. Finally, step IIIP cells are largely positive for adhesion molecules, including CD31, CD58, CD44, and 0.6%, CFU-M, 7.7% t 1.7%, CFU-GM, 8.8% t 1.6%.
VLA-4.
Control Experiments for HGFR Assay
Control experiments, particularly with respect to competition at receptor level between endogenous HGF and labeled ligand or MoAb, have been detailed in Materials and Methods.
Expression of HGFRs in Quiescent HPCs
In a first set of experiments we evaluated HGFR expression in quiescent step IIIP HPCs by immunofluorescence (Fig 4) and RT-PCR (Fig 5A and B) .
Immunofluorescence studies with PE-labeled anti-Jt3 and anti-c-kif MoAbs showed that 35% and 80% of cells were jt3' and c-kit', respectively. Futhermore, 40% to 45% of cells were labeled by biotin-labeled IL-6.
Studies with anti-IL-3R a-chain or anti-GM-CSFR achain MoAbs showed that the large majority (ie, 290% to 95%) of cells were IL-3R' and GM-CSFR'. These observations were confirmed by studies with PE-labeled GM-CSF (see below): however, the percentage of GM-CSFR' cells was slightly lower (>70%) than that obtained using anti-GM-CSFR MoAb (see below).
Finally, studies with PE-labeled G-CSF showed a reactivity with only a minority of cells.
RT-PCR analysis. mRNAs encoding HGFRs for earlyacting (bFGF, KL, and IL-6) and multilineage (IL- GM-CSF) cytokines werc expressed at significant levels in quiescent HPCs (Fig 5A) . In contrast, mRNAs encoding HGFRs for late, unilineage cytokines (Epo, G-CSF, M-CSF, and Tpo) were barely (Fig SB, top The unilineage differentiation culture systems. Experiments were performed to evaluate the expression kinetics of HGFRs during unilineage E, G, Mk, and Mo differentiation/ maturation of step HIP HPCs in liquid suspension culture. The main features of these culture systems have been extensively reported4."." and are further detailed in Table 2 .
Day 0 step IIIP HPCs, assayed in E, G, Mk, or Mo clonogenetic cultures (ie, in unilineage semisolid cultures treated with the same HGF stimuli of corresponding unilineage liquid cultures), generated only the expected E, G, Mk, or Mo colonies, respectively. The frequency of these colonies varied for the different lineages, ie, 28%, 16%. 7%, and 4% for the E, G, Mk, and Mo lineages, respectively (Table 3) .
During the first week of E, G, Mk, or Mo liquid culture the HPC number, assayed in secondary unilineage semisolid cultures, showed a gradual increase, ie, an increasing number of selectively E, G, Mk, or Mo colonies, respectively: this indicates unilineage HPC proliferation, ie, growth of E-, G-, Mk-, or Mo-committed HPCs in the corresponding cul-(and Table 2 and results not shown). Cell proliferture4. 19.21. 25 ation was associated with progressive HPC differentiation, as shown by a gradual decrease of the size of the unilineage colonies generated in secondary semisolid culture (Table 3) and the percentage of CD34' cell^.^.'^.^^ In the Mo lineage the decrease of colony size from day 0 to day 7-9 was less rapid than for the other lineages (Table 3) : in the second culture week the survival of a miniscule CFU-M population (eg. -3% of total cells on day 12) is seemingly related to the capacity of FL to stimulate the proliferation of primitive HPCs and CFU-GM. 4 Unilineage cultures were supplemented with an early-acting HGF (FL in Mo culture) or multilineage HGFs (IL-3, GM-CSF in E and G culture, in part Tpo in Mk culture).g6 Addition of these HGFs may allow the proliferation of HPCs not restricted to unilineage differentiation. To investigate this aspect, HPCs were sequentially collected from unilineage cultures and assayed in semisolid medium supplemented with saturating levels of KL, FL, multilineage (IL-3, GM-CSF), and unilineage (Epo, G-CSF, Tpo, M-CSF) HGFs: these clonogenetic culture conditions allow to assay the differentiation potential of the HPCs growing in liquid unilineage culture. The results (not shown here, see Discussion) indicate that other categories of HPCs survive in unilineage cultures, ie, HPCs with CFU-GEMM/CFU-GM potential in E culture, with CFU-GEMM/BFU-E potential in G and Mo culture, with CFU-GEMM/BFU-E/CFU-GM potential in Mk culture: it is crucial that the frequency of these HPCs rapidly declines in the first culture week, ie, these HPCs are either gradually channeled into the unilineage differentiation pathway or undergo apoptosis.
During the second week of culture the cell clonogenetic capacity is lost (ie, the size of generated clusters is below the colony scoring threshold, except for a few monocytic colonies in Mo culture, see above): HPCs enter into the maturation compartment and progressively express the morphologic, antigenic, and functional pattern of maturing E, G, Mk, and Mo precursors in the respective cultures.
The cell number amplification from day 0 through day 14-16 sharply differs in the four unilineage culture systems:
-IO'-fold for the E series, -1 02-fold for the G lineage, 30-and 12-fold for the Mo and Mk pathways, respectively. These differences seemingly reflect the frequency and particularly the proliferative potential of the different types of HPCs in step IIIP cells. (Fig 5A) indicated that the mRNA expression of early-acting HGFRs (bFGFR-I, c-kit, and IL-6R) was generally characterized by a progressive decline in both E and G differentiation pathways. bFGFR-I mRNA declined more rapidly during E than G differentiation, whereas the decrease of c-kit mRNA is slower in the E than G pathway. In previous studies' j t 3 mRNA showed an abrupt decrease in the E pathway and a slower decrease in the G series. IL-6R mRNA also declined to undetectable or low level in E and G maturation, respectively.
Immunofluorescence studies with anti-jt3 or anti-c-kit decreased during E and G differentiation, slightly more rapidly in the former than the latter lineage ( Figs 6A and  7A) . The number of c-kit+ cells slowly decreased in the E and G series to low levels at day 12 or 9, respectively (representative results in Fig 6B) : thus, the decline was less rapid in the E than the G lineage (Fig 7A) . Similar results were obtained using biotin-conjugated c-kit (data not shown).
Further immunofluorescence experiments were performed on Mk and Mo cultures (Fig 7A) : thejt3 and c-kit expression pattern in these lineages was similar to that observed for the E and G series. In Mo culture, however, we cannot exclude downmodulation o f j t 3 by the saturating FL level present in the medium (see below studies on G- Experiments with biotin-conjugated IL-6 showed that IL-6R expression ( I ) rapidly decreased to undetectable levels in the E series, (2) slowly decreased in the G series, (3) was sustained until day 7 and then decreased during Mk differentiation, and (4) increased through day 9 and remained detectable until terminal maturation in Mo lineage (Fig 7A,  see also Fig 6C) .
Expression of Multilineage HGFRs
The expression pattern of HGFRs specific for IL-3 and GM-CSF was investigated in the E and G lineages at mRNA level by RT-PCR and in all lineages at protein level by immunofluorescence.
RT-PCR analysis. ( I ) As shown in Fig 5A, IL-3R mRNA was briskly downmodulated in the E series to undetectable level at day 9, while it was sustained or slightly decreased in the G pathway; (2) GM-CSFR mRNA was characterized by a gradual decrease to low or undetectable level in advanced maturation in the E pathway, compared with a moderate decrease in the maturing G lineage.
Fluorescence studies with anti-GM-CSFR and -1L3R MoAbs and PE-labeled GM-CSF provided results in line with those observed at mRNA level.
At day 0-2, HPCs differentiating along either the E and G lineages were almost all IL-3R'. Starting from day 5 IL-3R' cells rapidly decreased in E culture, whereas expression in the G lineage was essentially unmodified, as evaluated in terms of IL3R' cell frequency (60% to 70% IL-3R' cells at day 12) and fluorescence intensity. IL3R expression progressively and sharply declined during Mk differentiation, almost as rapidly as in the E lineage. The decrease of IL3R expression was slow in the Mo series and a significant proportion (-50%) of mature monocytes displayed IL-3Rs. Similar results were obtained using anti-GM-CSF MoAb (Fig 6F and results not shown) and PE-labeled GM-CSF (Fig 7B) . However, the MoAb assay was more sensitive: this is seemingly caused by amplification of the MoAb fluorescence signal (see Materials and Methods) rather than by receptor occupancy by exogenous GM-CSF in E and G culture (the supplemented cytokine concentration causes only 4% receptor oc~upancy,'~ see above).
During the first 5 culture days virtually all cells differentiating along the E and G lineages were GM-CSFR', particularly by MoAb assay. In the second week, E precursors exhibited a gradually reduced reactivity with anti-GM-CSFR MoAb, ie, a moderate decrease of percent positive cells combined with a pronounced decline of fluorescence intensity. G precursors remained prevailingly (by ligand assay, Fig 7B) or completely (by MoAb assay, Fig 6F) GM-CSFR', but showed a sharp decrease of fluorescence level. Interestingly, the expression patterns of GM-CSFR evaluated by RT-PCR (Fig 5A) and MoAb (Fig 6F) assays are very similar.
In the Mk and Mo pathways GM-CSFR expression is characterized by a sustained majority of GM-CSFR' cells, coupled with a gradual decrease of fluorescence intensity, particularly in the Mk pathway (Fig 7B; also results not shown performed by MoAb assay).
Expression of Late-Acting Unilineage HGFRs
The expression of EpoR, G-CSFR, TpoR, and M-CSFR was investigated in the four differentiation pathways by RT-PCR analysis (Fig 5B) .
These HGFRs, only scarcely expressed in quiescent HPCs, were gradually induced and then sustainedly expressed in the pertinent lineage. Conversely, they are barely or not expressed in the other lineages: (1) EpoR mRNA was transiently expressed at low level in the G and Mk lineages from IL-3R assay.
GM-CSFR assay.
For day 2 to 5 and day 9 to 14 respectively, while it was not detected in the Mo series; ( 2 ) G-CSFR mRNA was transiently expressed at low level in day 2-5 E culture, and barely detected in the Mk and Mo series until initial maturation; ( 3 ) M-CSFR was transiently expressed at low level in day 2 E culture, barely detected in G lineage until maturation and absent in the Mk series; and (4) TpoR mRNA was barely or not detected in E, G and Mo cultures.
These findings were confirmed by fluorescence studies quantifying the binding of PE-labeled G-CSF to HPCs differentiating along the E, G, Mk, and Mo lineages ( Figs 6G and  7B) . The G-CSF binding, barely present on quiescent HPCs, was mildly induced in E, Mk, and Mo differentiation at day 2-5, then progressively decreased. In the G lineage the early receptor induction was followed by temporary downmodulation and then a rebound up to the initial induction level.
Two series of control experiments indicated that the saturating G-CSF level added in the G culture partially downmodulates membrane G-CSFRs. Thus, (1) step IIIP cells were grown from day 0 to 2 in a modified G culture system, treated with standard IL-3 and GM-CSF concentrations (1 U/mL and 0.1 ng/mL, respectively) combined or not with graded concentrations of G-CSF up to the level in G culture (5,50, or 500 U/mL); thereafter, G-CSF bound to cell membrane was removed (see Materials and Methods) and G-CSF binding was measured with PE-labeled G-CSF. Cells cultivated in the presence of 500 U/mL G-CSF displayed a lower G-CSF binding capacity than those grown without G-CSF or with 5-50 U/mL G-CSF (Table 3) . (2) Unilineage HPC differentiation along the G pathway was induced by treatment with standard IL-3/GM-CSF levels without G-CSF addition (in this modified unilineage culture, G-cell growth is slower than in standard G culture, results not shown): interestingly, granulopoietic cells displayed higher percentages of G-CSFR' cells in G-CSF-modified G culture than G-CSF' standard G culture (Fig 7B) . The G-CSFR expression patterns evaluated at protein level in G-CSF-culture (Fig 7B) and at mRNA level in G-CSF' culture (Fig 5B) are strictly consistent.
DISCUSSION
The analysis of key mechanisms controlling human hematopoiesis has been hindered by lack of (1) methodology for stringent purification and abundant recovery of HPCs and (2) culture systems for unilineage differentiation/maturation of the purified HPCs. Thus, little is known on HGFR expression in hematopoiesis, particularly at discrete stages of HPC differentiatiodmaturation along the different lineages. We have recently developed novel culture techniques to selectively channel HPC proliferation along the different seOn this basis, we have analyzed the expression of an extensive series of HGFRs on 90% purified HPCs undergoing strictly unilineage E, G, Mk, or Mo differentiationlmaturation.
The HGFR assays provided consistent results. The mRNA levels of c-kit, IL-6R, IL-3R, and GM-CSFR, evaluated by semiquantitative RT-PCR, were compatible with corresponding protein results obtained by MoAb andor labeled ligand assay(s): this suggests that posttranscriptional mechanisms do not play a major role in the expression of these HGFRs.
In protein assays, receptor occupancy by its ligand supplemented in culture was carefully considered: a series of control studies insured that this potential bias did not obscure results and interpretation thereof (see Results).
As previously mentioned, we reported that quiescent HPCs purified from PB express IL-3Rs at elevated level and IL-6Rs/GM-CSFRs at moderate level, whereas EpoRs were barely dete~tab1e.l~ We confirm these results and further show that receptors for early-acting HGFs (bFGF, flt3, and I U ) are clearly expressed on the purified HPCs, whereas the receptors for other unilineage HGFs (G-CSF, M-CSF, and Tpo) are barely or not expressed. This pattem is in line with BM studies showing that: (1) flt3R is selectively expressed on CD34' cells4'; (2) c-kit is present on early/late HPCS,~~.'' whereas ILdR is present on different HPC subsets including 34+/33-and 34+/33+ cells5'; (3) M-CSFR," G-CSFR," and TpoR" are scarcely expressed on CD34' cells. However, these studies were carried out on BM CD34+ cells displaying a low or moderate HPC clonogenetic efficiency (comprised between 2% and 35%). c-kit was also detected on putative HSCS.'~ In the unilineage cultures HPC differentiation and precursor maturation gradually progress in the first and second week, r e s p e c t i~e l y~~~~-~~ (see also Table 3 ).
HPC differentiation in the first week deserves discussion. The E, G, Mk, and Mo culture systems are respectively fed by BFU-E, CFU-GM, CFU-Mk, and CFU-M. The proliferating HPCs gradually differentiate along the unilineage pathway, as indicated by the progressive decrease of ( I ) their proliferative potential and (2) CD34 expression. Early-acting and multilineage HGFs added to these cultures may initially allow the survival of HPCs not restricted to the unilineage fies.4,19-25 differentiation: it is suggested that these HPCs are either gradually channeled into the unilineage pathway or undergo apoptosis (see Results). Thus, both selective and inductive phenomena may underlie HPC differentiation in unilineage cultures. Accordingly, studies on the differentiation of primitive HPCs' and multilineage GF-dependent cell linesS5 suggest that late-acting HGFs modulate HPC differentiation allowing the survival of selected categories of HPCs. whose differentiation capacities are intrinsically determined. However, the HPC differentiation program, although partially preprogrammed, is in part induced by HGF(s) through mechanisms other than anti-apoptotic ones.56 Furthermore, we observed that the percentage of apoptotic cells is (1) low (ie, < 10%) in E and G cultures, where the initially responsive HPC subpopulation is relatively large, and (2) more elevated (ie, 530%) in Mk and Mo cultures, where the initially responsive HPC subpopulation is relatively small (results not shown).
In the second culture week, we monitored a gradual wave of unilineage maturation of morphologically recognizable precursors along the E, G, Mk, or Mo pathway through terminal maturation.
Expression of early-acting HGFRs (bFGFR-1, jt3, c-kif) consistently decreases during hematopoietic differentiation. IL-6R expression similarly declines in the E and C lineages, but is maintained until the early or late stages of maturation in the Mk and Mo lineages, respectively. The persistent expression in the two latter series is consistent with the two biologic activities of IL-6, which stimulates in vitro" and in vivosx megakaryocytopoiesis and potentiates the proliferation of monocytes in clonogenetic5' and unilineage Mo culture (our unpublished observations).
The expression kinetics of multilineage HGFRs differs in the four lineages. The IL-3R is rapidly downmodulated in E and Mk differentiation, while the expression slowly declines in the Mo pathway and is sustained in the G lineage, thus leading to significant IL-3R expression on terminal Mo and particularly G cells. The GM-CSFR, although downmodulated in all series with respect to receptor density, is still detected by MoAb assay on virtually all terminal G, Mo, and Mk cells. These expression patterns are in line with the biologic activity of IL-3 and GM-CSF: (1) both stimulate the proliferation of early HPCs and their differentiation along the G, Mo, E, and Mk pathways"; (2) their combined action channels purified HPCs into G differentiationlmaturation coupled with a 5 5 % to 10% Mo cell component'y~2'~22; (3) both sustain the functional activity of neutrophils and monocytes.'".'' 
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